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Distinguishing whether pulmonary mycobacterial disease is due to Mycobacterium 
tuberculosis or nontuberculous mycobacteria (NTM) has important clinical and public 
health implications. There are limited data comparing these groups of patients, particularly 
from developing countries in the era of HIV infection. South African mineworkers have high 
rates of tuberculosis (TB), NTM disease and HIV infection. The study took place in a hospital 
serving four gold mines. All men with a positive sputum mycobacterial culture in 1995 were 
enrolled. Patients were interviewed, sputum and blood samples obtained and a chest 
radiograph taken. We compared clinical, laboratory and radiological features in those with 
TB with those with NTM disease (mainly Mycobacterium kansasii). Treatment outcomes are 
reported for those with pulmonary disease due to M. kansasii. The 425 patients with TB and 
51 with NTM disease showed no significant difference in HIV status. Of patients with a 
positive smear, 91.3% (314/344) cultured M. tuberculosis. Patients with TB weighed less 
(p=0.03) and had lower haemoglobin levels (p<0.001). Those with NTM were less likely to 
have extensive radiographic changes (OR 0.27) than those with TB. Those with NTM were 
more likely to have silicosis (OR 9.7). Fourteen of the 36 patients with M. kansasii pulmonary 
disease had a positive culture at six months and a further 11 had a positive culture in the 
follow-up period. Patients with TB had features of more aggressive disease. The current 
practice of treating smear-positive patients as TB seems reasonable. Treatment failure and 
relapse were common in those with disease due to M. Kansasii.
Introduction 
Pulmonary mycobacterial disease may be due to 
Mycobacterium tuberculosis  or nontuberculous 
mycobacteria (NTM). Differentiating the causative organism 
has important clinical and public health implications. 
Infection due to NTM is usually acquired from 
1
environmental sources  and public health tuberculosis (TB) 
control measures, such as contact tracing, would thus not be 
indicated in patients with NTM disease. The treatment 
regimen for patients with NTM disease differs from that for 
1-3
TB.  There are limited data comparing a variety of clinical 
(eg. weight) and laboratory (eg. haemoglobin levels, T-cell 
counts) findings in these groups of patients.
South African mineworkers have high rates of TB, NTM 
disease and HIV infection. In a study of risk factors for NTM 
disease compared to TB in miners, we showed that previous 
TB treatment, silicosis and longer duration of underground 
work were more strongly associated with NTM disease than 
4
TB.  In this paper, we aim to identify clinical, laboratory and 
radiological features that differentiate patients with disease 
due to NTM and M. tuberculosis. We also report outcome of 
treatment in those with disease due to Mycobacterium 
kansasii.
Materials and methods
The study was undertaken in a hospital that serves men 
working on four South African gold mines. A comprehensive 
TB control programme, including both active (chest 
radiographic screening and contact tracing) and passive case-
finding, is in place. Men with symptoms suggestive of TB are 
referred from the primary healthcare facilities to the hospital 
where a diagnosis is made and treatment initiated. TB 
suspects routinely have three sputum smear examinations; a 
minimum of one specimen is cultured, and the organism is 
identified and tested for drug resistance. Treatment for TB 
comprises two months of isoniazid (H), rifampicin (R), 
pyrazinamide (Z) and ethambutol (E), followed by four 
months of isoniazid and rifampicin (2HRZE/4HR). Patients 
with multidrug resistance are treated according to their drug 
sensitivity pattern. Smear-positive patients are initially 
hospitalised, after which they report every weekday to the 
primary healthcare facilities, where directly observed 
therapy is practised. Smear-positive patients are presumed to 
have TB and are started on anti-TB therapy (HRZE). Culture 
results are available after approximately six weeks, at which 
stage therapy is individualised for NTM patients: patients 
who are smear-positive have their regimen changed to 
2HRZE/4HRE; patients with a negative smear and single 
NTM culture, who are clinically well, are not treated but are 
followed up in the routine surveillance system; those who are 
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clinically unwell have a second sputum specimen sent for 
microscopy and culture and are reviewed six weeks later. 
Patients who do not respond to this first-line treatment have 
repeat cultures and their regimen is altered according to the 
organism and drug susceptibility results. 
All patients with at least one positive sputum mycobacterial 
culture in 1995 were prospectively enrolled in the study. 
Details of the study methods have been previously 
5
described.  Patients were interviewed, sputum and blood 
samples obtained and a chest radiograph taken. Weight loss 
was assessed by subtracting the weight on admission from 
the highest recorded weight since commencing employment 
(miners are usually weighed on return from annual leave). 
Anaemia was defined as a haemoglobin level of <12g/dl. 
An attempt was made to obtain two specimens for 
mycobacterial culture from each patient, prior to 
commencing treatment, on different days, to reduce the 
possibility of laboratory contamination. Sputum smears, 
using fluorescent microscopy with auramine stain, were 
performed according to standard methods. Sputum 
specimens were inoculated into Bactec 12B vials after 
decontamination. Isolates of acid-fast bacilli were identified 
using DNA-RNA hybridisation (Gen-Probe AccuProbe, San 
Diego, California, USA) for M. tuberculosis, M. kansasii and 
Mycobacterium avium complex. Standard biochemical tests 
and morphological assessment on a Lowenstein-Jensen slope 
6
were used to identify all other species.  Pulmonary TB was 
diagnosed if at least one sputum culture grew M. 
tuberculosis. The diagnosis of pulmonary NTM disease was 
made in patients with at least two sputum cultures that were 
positive for the same nontuberculous mycobacterium. 
Postero-anterior chest radiographs, taken at diagnosis, were 
read jointly by two readers blinded to the culture result, HIV 
status and clinical data. To assess extent of radiographic 
changes each lung was classified into upper, middle and 
lower zones. Severity was classified as minimal if there was 
slight to moderate involvement in one or both lungs, but the 
total extent of lung affected did not exceed one zone; 
moderate if multiple zones were affected but with intervening 
areas of normal lung; and extensive if multiple zones were 
affected with minimal normal lung present. Radiographs 
were considered to be typical of TB if there were 
predominantly upper zone infiltrates/fibrocavitation or 
miliary disease. A radiograph was considered atypical if 
changes, including cavitation, were present predominantly in 
the lower lung fields, if there was isolated hilar and/or 
mediastinal lymphadenopathy, if there was lobar 
consolidation or if there were no changes. Silicosis was 
recorded as present (International Labour Office (ILO) 
category 1/1 or higher), possible (ILO category 1/0 or 0/1) or 
7
absent (ILO category 0/0 or 0/-).  
T-cell analysis was determined by flow cytometry using 
SimulSet monoclonal antibodies and FACSort (Becton 
Dickinson, San Jose, California, USA). Relative levels of 
CD4+ and CD8+ lymphocytes expressed as percentages of 
total lymphocytes, which are less variable than absolute 
8
counts, were used.  A CD4 percentage of >28% corresponds 
to an absolute CD4 count of >500/uL, 14-28% corresponds to 
9
200-499/uL and <14% to <200/uL.  
Treatment outcomes for subjects with TB have been 
5
discussed in detail previously.  For the purposes of this paper, 
outcomes in those subjects who had pulmonary disease due 
to M. kansasii are reported. Sputum was cultured six months 
after enrolment into the study and subjects were followed 
through the routine follow-up system until October 1998. 
Ethics approval was obtained from the University of the 
Witwatersrand and the London School of Hygiene and 
Tropical Medicine.
Data were entered and analysed using Epi-Info 6.02 (WHO, 
Geneva and CDC, Atlanta) and STATA 5.1 (Stata 
corporation, Texas). Continuous variables were compared 
using the t-test. Categorical variables were analysed using 
the chi-squared test if binary or the chi-squared test for trend 
if ordinal. In addition to the crude odds ratios (ORs) obtained 
from the univariate analysis, a logistic regression analysis 
was undertaken, in which each clinical manifestation was 
adjusted for factors previously identified as being linked to 
the development of TB or NTM disease (previous TB 
treatment, silicosis, years working underground and alcohol 
4
consumption).  Age and HIV status were included in the 
model a priori.
Results
During 1995, 505 men had a sputum specimen that was 
positive on mycobacterial culture. Of these, 425 specimens 
grew M. tuberculosis alone and 51 had two or more positive 
NTM cultures (NTM disease). The remaining 29 patients 
were excluded from the analysis: sputum from seven patients 
grew both M. tuberculosis and an NTM on the same 
specimen (mixed infections) and in 22 patients there was a 
single positive NTM culture. In these mines, the period 
prevalence of pulmonary TB in 1995 was 1515 per 100 000 
population (432/28 522) and that for NTM disease was 179 
per 100 000 population (51/28 522).
The spectrum of NTM organisms cultured is shown in Table 
1. M. kansasii was the predominant organism (67%). Forty-
eight of 51 NTM patients had the same NTM organism on all 
cultures while in three patients one culture isolated a mixture 
of M. kansasii and MAI. Over half of the NTM patients had a 
history of TB treatment. Eighteen (35.3%) of the 51 patients 
with NTM disease were HIV-infected. The various NTM 
species were cultured in both HIV-positive and -negative 
patients, except Mycobacterium abscessus where both 
patients were HIV-negative.
The clinical and laboratory features of the NTM patients 
were compared with those with pulmonary TB (Table 2). The 
age distributions were similar. The mean weights on 
admission were 60.5 kg and 58.3 kg in those with NTM and 
TB, respectively (p=0.03). Of patients with a positive smear, 
91.3% (314/344) cultured M. tuberculosis. The mean 
haemoglobin was 13.6 g/dl in patients with NTM and 12.7 
g/dl in those with TB (p<0.001). In patients with NTM, 
52.9% had previously taken anti-TB treatment compared to 
25.4% of TB patients (p<0.001).
Comparison of radiological features in patients with NTM 
and TB is shown in Table 3. Examples of the spectrum of 
chest radiographic changes in patients with NTM disease and 
TB are shown in Figures 1-3. One patient with NTM (2.0%) 
and eight with TB(1.9%) had no changes on chest 
radiograph. None of these patients had previous TB 
treatment, and all but two (both TB patients) were HIV-
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Table 1: NTM organism, history of TB treatment, HIV status and degree of 
immunosuppression in 51 gold miners
Total Previous TB HIV- positiveCD<14%*
n (%) n n n
34 (66.7) 15 11 4
1 2 0
Total 51 27 18 9
* 
In HIV- positive subjects. CD4 of <14% corresponds to CD4 count of <200 cells/L. CD4 not 
available on one patient with M. kansasii infection
M. kansasii
MAI 9 (17.6) 7 4 4
M. abscessus 2 (3.9) 2 0 -
M. scrofulaceum 3 (5.9)
Mixed MK/MAI 3 5.9 2 1 1
Table 2: Comparison of clinical and laboratory features in patients with NTM disease and pulmonary TB 
NTM TB Crude Adjusted*
n=51 n=425 OR 95% CI P value OR 95% CI P value
n % n %
Clinical
Admission weight n=473
<55kg 11 21.6 117 27.7 1 0.02 1 0.02
55-64kg 23 45.1 235 55.7 1.0 0.49-2.2 1.00 0.44-2.25
³65kg 17 33.3 70 16.6 2.6 1.1-5.9 2.88 1.18-7.06
Weight loss n=458
Stable/ gained weight 4 8.2 38 9.3 1 0.1 1 0.06
1-4kg 26 53.1 161 39.4 1.5 0.50-4.7 1.27 0.40-4.04
5-9kg 13 26.5 110 26.9 1.1 0.34-3.7 0.85 0.24-2.98
³10kg 6 12.2 100 24.4 0.57 0.15-2.2 0.46 0.11-1.84
Laboratory
Sputum smear n=476
Negative 21 41.2 111 26.1 1 1
Positive 30 58.8 314 73.9 0.51 0.28-0.92 0.03 0.39 0.20-0.76 0.006
HIV n=475
Negative 33 64.7 217 51.2 1 1
#
Positive 18 35.3 207 48.8 0.57 0.31-1.1 0.07 0.67 0.35-1.29 0.2
CD4% (in HIV+) n=215
>28% 9 52.9 94 47.5 1 0.4 1 0.4
14-28% 7 41.2 75 37.9 0.97 0.35-2.8 0.77 0.24-2.45
<14% 1 5.9 29 14.6 0.36 0.04-3.0 0.40 0.05-3.51
Anaemia n=458
No 41 85.4 257 62.7 1 1
Yes 7 14.6 153 37.3 0.29 0.13-0.66 0.003 0.30 0.13-0.72 0.007
* Adjusted for risk factors: age, HIV status, previous TB treatment, silicosis, years working underground and alcohol consumption
#
 Adjusted for age, previous TB treatment, silicosis, years working underground and alcohol consumption 
Figure 1: Chest radiograph of a patient with numerous positive 
cultures for M. kansasii, showing features typical of TB Figure 2: Extensive bilateral cavitary pulmonary TB 
Table 3: Comparison of chest radiographic findings in patients with NTM disease and pulmonary TB 
NTM TB Crude Adjusted*
n=51(10.8%) n=422(89.2%) OR 95% CI P value OR 95% CI P value
n % n %
Extent of changes
Nil / Minimal change 17 33.3 96 22.8 1 0.3 1 0.007
Moderate change 20 39.2 207 49.1 0.55 0.27-1.1 0.27 0.12-0.60
Extensive change 14 27.5 119 28.2 0.66 0.31-1.4 0.27 0.11-0.66
Pattern
Typical 41 80.4 356 84.4 1 1
Atypical 10 19.6 66 15.6 1.32 0.63-2.8 0.5 2.09 0.87-5.03 0.1
Cavitation
No 19 37.3 232 55.0 1 1
Yes 32 62.7 190 45.0 2.06 1.1-3.8 0.02 1.29 0.62-2.54 0.5
Upper zone involvement
No 5 9.8 4.0 9.5 1 1
Yes 46 90.2 382 90.5 0.96 0.36-2.3 0.9 0.56 0.19-1.7 0.3
Silicosis
No 37 72.5 357 1 1
Possible 11 21.3 63 14.9 1.69 0.81-3.5 0.2 1.36 0.62-2.98 0.8
Yes 3 5.9 3 0.7 9.65 1.8-51 0.001 12.6 2.22-71.3 0.004
Unilateral 
No 36 73.5 303 73.5 1 1
Yes 13 26.5 109 26.05 1.00 0.51-2.0 1.0 1.55 0.72-3.31 0.3
Side
Left 4 30.8 45 41.3 1 1
Right 9 69.2 64 58.7 1.58 0.46-5.5 0.5 0.77 0.17-3.62 0.7
Pleural involvement
No 39 76.5 322 76.3 1 1
Yes 12 23.5 100 23.7 1.00 0.50-2.0 1.0 0.70 0.33-1.49 0.3
Fibrosis
No 36 70.6 311 73.7 1 1
Yes 15 29.4 111 26.3 1.18 0.62-22 0.6 0.64 0.31-1.35 0.2
* Adjusted for risk factors: age, HIV status, previous TB treatment, silicosis, years working underground and alcohol consumption
Figure 3: Atypical radiographic presentation of pulmonary TB 
in an immunocompromised patient
positive. Patients with NTM and TB had similar radiological 
findings in terms of features typical of TB, upper zone 
involvement, unilateral disease, left or right-sided changes, 
pleural involvement and fibrosis. Patients with NTM were 
more likely to have radiographic features of silicosis. After 
adjustment for age, HIV status, previous TB treatment, 
silicosis, years working underground and alcohol 
consumption, those with NTM were less likely than TB 
patients to have moderate to extensive radiological changes. 
The association with cavitation seen on univariate analysis 
was confounded by previous TB treatment.
Of 36 cases with M. kansasii pulmonary disease, 14 had a 
positive culture for M. kansasii six months after study entry 
in 1995. A further 11 were known to have had a positive 
culture in the follow-up period. Thus, 25 of 36 (69%) cases 
were known to have failed treatment. Five men later 
developed TB. One HIV-positive man died 4½ months after 
diagnosis and a further four men (two HIV-positive) died 
during follow-up. 
Discussion
In developed countries, with the spread of the HIV epidemic, 
disease attributable to NTM has increased both in actual 
3
numbers and as a proportion of all mycobacterioses.  The 
major burden of the HIV epidemic, however, is in developing 
countries, particularly in sub-Saharan Africa, and this has 
resulted in an increased incidence of both pulmonary and 
10
extrapulmonary TB.  Disease due to NTM is potentially a 
cause of morbidity and mortality in African patients with 
advanced immunosuppression. 
The rates of TB and pulmonary NTM disease in this 
population of gold miners are extremely high. In a previous 
prospective cohort study in a South African gold mining 
workforce, the incidence of NTM disease (meeting the ATS 
case-definitions of definite disease and excluding chronic 
11
cases) was 47.6 per 100 000 employee years.  The 
prevalence of NTM disease in the mines in 1995 in this study 
(179 per 100 000 population) is higher, but case definitions 
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differed and all cases (new and previous treatment) were 
included. The spectrum of NTM organisms, and the 
predominance of M. kansasii infection, are similar in the two 
12
settings.  Similarly, periodic surveys in the 1980s, prior to 
the HIV epidemic, from one mine hospital showed that the 
commonest NTM organism was M. kansasii (79%), with M. 
scrofulaceum, M. intracellulare, M. fortuitum and M. terrae 
13
were also isolated.  
There is geographical variation in the prevalence of NTM 
disease and the mycobacterial species responsible for 
1
infection.  It is estimated that in Great Britain, between 1952 
and 1978, there were approximately 200 cases of infection 
with atypical mycobacteria per year, an incidence of 0.4 per 
14
100 000 population, most often due to M. kansasii.  In the 
United States in the early 1980s, prior to the HIV epidemic, 
the prevalence of NTM pulmonary disease was estimated to 
15
be 1.8 per 100 000 population.  In Japan, where 
pneumoconiosis is the most prevalent occupational disease, 
NTM incidence rates have been estimated at 1.7 cases per 
100 000 population per year, with 90% of disease due to 
16
MAI.  Incidence is high in some areas of the Czech Republic 
(12.4 per 100 000), which may be linked to contaminated 
17
water.  In developing countries, national rates of NTM 
disease are usually unavailable, as cultures on suspected TB 
patients are often not routinely performed. Reported rates of 
TB therefore probably include a proportion of NTM patients. 
In a 1989-1990 cross-sectional study in Nigeria, of the 188 
patients with a positive sputum mycobacterial culture, 73% 
cultured M. tuberculosis, with M. kansasii being the most 
18
common NTM.  In Guinea-Bissau (1992-1993), 17 (8%) of 
19
positive sputum cultures from 206 patients isolated MAC.  
In countries with a high incidence of TB, the proportion of 
mycobacterial cultures that isolate NTM is generally low. In 
1977, of 4 923 positive mycobacterial cultures at the South 
African Institute for Medical Research, 2.1% cultured NTM 
20
strains.  In contrast, in the United States, the rate of disease 
attributable to M. avium is approximately 13% that of 
3
pulmonary TB.  In our study, of all cases with mycobacterial 
disease, 11% had disease due to an NTM. Similar proportions 
were found in other mines in the 1980s (8-12% in patients 
13
with a first episode of disease and 21% in those with relapse)  
12
and more recently (11.5% and 19.5%, respectively).
We demonstrated the broad spectrum and overlap of clinical 
features of pulmonary disease due to NTM and M. 
tuberculosis. Even though we studied a broader range of 
clinical, laboratory and radiological features than in previous 
studies, we did not find any pathognomonic features that 
indicated whether the patient had TB or NTM disease. 
However, those with TB were more likely to weigh less, have 
lower haemoglobin levels and have more extensive 
radiographic changes, suggesting more aggressive disease. 
Furthermore, by adjusting for known risk factors, it was 
possible to estimate whether the difference in clinical 
features was a feature of the underlying disease process or a 
manifestation of a particular risk factor. For example, 
patients with NTM disease weighed more than those with 
TB, independent of HIV status; and, after controlling for risk 
factors including previous TB treatment, HIV status and 
silicosis (all of which may influence radiographic features), 
those with TB had more extensive chest radiographic 
changes. 
The wide spectrum of clinical disease due to NTM ranges 
from infected bullae that heal spontaneously to progressive 
3
destructive lung disease.  Signs and symptoms are variable 
and are often non-specific, including chronic productive 
cough, fatigue, fever, haemoptysis, dyspnoea and weight 
1
loss.  Although the chest radiographic features of NTM 
pulmonary disease often mimic those of TB, other 
21-24
radiological appearances have been described.  Studies 
25
comparing these patients report that haemoptysis  and 
unilateral right-sided radiographic changes with lower lobe 
21,26
involvement with smaller cavities  were more common in 
those with NTM disease. In a retrospective case series, 
comparison of radiological features in patients with disease 
due to M. kansasii or M. tuberculosis found that those with 
the NTM were more likely to have radiographs showing focal 
27
scarring, silicosis and old cavitation.  As in our study, they 
were less likely to have extensive radiological changes. Our 
21-24,26
findings concur with previous reports  that the chest 
radiograph is unhelpful in differentiating between TB and 
NTM disease. Patients with pulmonary TB may have a 
28
normal appearance on chest radiograph  and the presence of 
chest radiographic changes as a necessary criterion for NTM 
disease has been challenged, particularly in patients with 
22,23
AIDS.
A previous prospective study in a gold mine found that 
miners develop M. kansasii disease at an early stage of HIV 
infection and that disease prevalence is independent of HIV 
29
status.  Similarly, we found that those with NTM were less 
often HIV-positive than those with TB and that few (4/34) of 
our HIV-positive patients with disease due to M. kansasii 
were severely immunocompromised. 
Using a short-course regimen, treatment outcomes were poor 
for those with disease due to M. kansasii, with over two-
thirds of patients having positive cultures at six months and in 
the subsequent follow-up period. Some of these men also had 
M. tuberculosis during follow-up with important clinical 
implications, viz. there should be a high index of suspicion of 
TB even if a previous culture grew an NTM. Comparison of 
treatment outcomes between studies is difficult, since they 
have different diagnostic criteria, patient characteristics 
(including proportion with HIV infection), treatment 
regimens and length of follow-up.  Different studies have 
11,27
reported cure rates of 46% to 83%,  and relapse rates of 8% 
17,30
to 10%.  
This study highlights the diagnostic challenge of pulmonary 
mycobacterial disease in the era of the HIV pandemic. The 
study design and setting have a number of strengths: a large 
number of cases were diagnosed in a one year period; all 
patients, regardless of severity of disease, present to the same 
medical facility; the well-resourced medical services with 
availability of multiple sputum cultures make diagnosis more 
likely than in other developing country settings, and there 
were few missing data. Furthermore, there was systematic 
and prospective data collection and the same diagnostic 
work-up for those with possible TB or NTM disease. 
Although the minerkers were all silica-exposed men, the 
results presented adjust for risk factors, such as age, HIV 
status and silicosis and may be applicable to settings other 
than the mine environment.
 
With the large burden of mycobacterial disease seen in 
developing countries, a practical approach to the diagnosis 
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and management of patients is needed. Clearly the approach 
will be determined by the availability of resources and 
facilities. An important indicator was that those with NTM 
disease were less likely to be smear-positive than patients 
with TB. In this setting, with approximately 90% of all 
mycobacterial cultures culturing M. tuberculosis, the 
predictive value of a positive smear being TB was 91%. Thus, 
treating all smear-positive patients as TB, in settings with 
high rates of TB and where culture facilities are unavailable, 
seems appropriate. Comparison of patients with NTM 
disease and TB reinforces World Health Organization 
guidelines, with emphasis on smear-positive cases and 
treating all cases as TB in developing countries. 
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